Analysis of microalbuminuria with immunonephelometry and high performance liquid chromatography. Evaluation of new criteria;Immunnefelometria és nagy teljesítményu folyadékkromatográfia a microalbuminuria vizsgálatában. Újonnan javasolt határértékek vizsgálata

Orvosi Hetilap

Volumn 149, Issue 2, 2008, Pages 59-67

  Markó, Lajos ^a   Molnár Gergo, Attila ^a   Wagner, Zoltán ^a   Koszegi, Tamás ^b   Matus, Zoltán ^a   Mohás, Márton ^a   Kuzma, Mónika ^c   Szijártó István, András ^a   Wittmann, István ^a,d  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Laboratóriumi Medicina Intézet   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d Gyógyszerészi Kémiai Intézet ^*  (Hungary)

Author keywords

Diabetes mellitus; High performance liquid chromatography; Hypertension; Immunonephelometry; Microalbuminuria

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEPHELOMETRY; PREDICTION; SEX DIFFERENCE; URINALYSIS;

EID: 38849189973     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28187     Document Type: Article

References (25)

1. American Diabetes Association: Standards of Medical Care in Diabetes - 2007. Diabetes Care, 2007, 30, S4-41.
2. Lambers Heerspink, H. J., Brinkman, J. W., Bakker, S. J. és mtsai: Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Curr. Opin. Nephrol. Hypertens., 2006, 15, 631-636.
3. Mogensen, C. E.: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int., 1987, 31, 673-689.
4. Parving, H. H., Oxenboll, B., Svendsen, P. A. és mtsai: Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol. (Copenh), 1982, 100, 550-555.
5. Parving, H. H.: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med., 1994, 330, 937-938.
6. Parving, H. H., Lehnert, H., Brochner-Mortensen, J. és mtsai: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med., 2001, 345, 870-878.
7. Jarrett, R. J., Viberti, G. C., Argyropoulos, A. és mtsai: Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet. Med., 1984, 1, 17-19.
8. Messent, J. W., Elliott, T. G., Hill, R. D. és mtsai: Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int., 1992, 41, 836-839.
9. Hillege, H. L., Fidler, V., Diercks, G. F. és mtsai: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation, 2002, 106, 1777-1782.
10. Gansevoort, R. T., Verhave, J. C., Hillege, H. L. és mtsai: The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int., 2005, 94, S28-S35.
11. Brunskill, N. J.: Albumin handling by proximal tubular cells: mechanisms and mediators. Nephrol. Dial. Transplant., 2000, 15, 39-40.
12. Russo, L. M., Bakris, G. L. Comper, W. D.: Renal handling of albumin: a critical review of basic concepts and perspective. Am. J. Kidney Dis., 2002, 39, 899-919.
13. Burne, M. J., Panagiotopoulos, S., Jerums, G. és mtsai: Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria. Clin. Sci. (Lond), 1998, 95, 67-72.
14. Greive, K. A., Balazs, N. D. Comper, W. D.: Protein fragments in urine have been considerably underestimated by various protein assays. Clin. Chem., 2001, 47, 1717-1719.
15. Osicka, T. M., Houlihan, C. A., Chan, J. G. és mtsai: Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes, 2000, 49, 1579-1584.
16. Comper, W. D., Osicka, T. M., Jerums, G.: High prevalence of immuno-unreactive intact albumin in urine of diabetic patients. Am. J. Kidney Dis., 2003, 41, 336-342.
17. Greive, K. A., Eppel, G. A., Reeve, S. és mtsai: Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats. Am. J. Kidney Dis., 2001, 38, 144-152.
18. Osicka, T. M., Comper, W. D.: Characterization of immunochemically nonreactive urinary albumin. Clin. Chem., 2004, 50, 2286-2291.
19. Polkinghorne, K. R., Su, Q., Chadban, S. J. és mtsai: Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. Am. J. Kidney Dis., 2006, 47, 604-613.
20. Comper, W. D., Osicka, T. M., Clark, M. és mtsai: Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int., 2004, 65, 1850-1855.
21. Mc Queen, M. J., Gerstein, H. C., Pogue, J. és mtsai: Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study. Am. J. Kidney Dis., 2006, 48, 889-896.
22. Comper, W. D., Jerums, G., Osicka, T. M.: Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography. Clin. Biochem., 2004, 37, 105-111.
23. Sviridov, D., Meilinger, B., Drake, S. K. és mtsai: Coelution of other proteins with albumin during size-exclusion HPLC: Implications for analysis of urinary albumin. Clin. Chem., 2006, 52, 389-397.
24. Clavant, S. P., Sastra, S. A., Osicka, T. M. és mtsai: The analysis and characterisation of immuno-unreactive urinary albumin in healthy volunteers. Clin. Biochem., 2006, 39, 143-151.
25. Brinkman, J. W., Bakker, S. J., Gansevoort, R. T. és mtsai: Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney Int., 2004, 92, S69-S75.